Evaluation of Serum STARD3 Levels in Patients With Breast and Prostate Cancer: A Case-Control Study [0.03%]
乳腺癌和前列腺癌患者血清STARD3水平的检测：一项病例对照研究
Almila Nazlı Korucu,Mine Büşra Bozkurk,Dilara Şevval Anasız et al.
Almila Nazlı Korucu et al.
Objective: Cancer cells exhibit high metabolic demands and rely heavily on lipid metabolism for proliferation and membrane synthesis. Lipid transfer proteins, particularly the steroidogenic acute regulatory-related lipid ...
Ramita Mukherjee,Rachana Meena,Brijesh Kumar Singh
Ramita Mukherjee
Dermatofibrosarcoma protuberans (DFSP) is a rare, low-grade, fibroblastic mesenchymal tumor derived from the dermis. Breast is an uncommon site with an incidence of only 0.8-4.5% and an overall population incidence at any site of 4.2-4.5 pe...
Safe Delivery of Radiotherapy for Breast Cancer Patient With Left Ventricular Assist Device: Case Report and Review of the Literature [0.03%]
左心室辅助装置患者的乳腺癌放射治疗的安全性：病例报告及文献回顾
Senem Alanyalı,Emre Karaman,Murat Köylü et al.
Senem Alanyalı et al.
The increasing use of cardiac artificial devices, such as cardiac implantable electronic devices (CIED) and left ventricular assist devices (LVAD), results in longer life expectancy and thus may eventually coincide with a risk of cancer dia...
Lymphedema and Axillary-Lateral Thoracic Vessel Juncture Irradiation: A Clinical Dilemma [0.03%]
淋巴水肿与腋旁胸壁血管照射：一个临床难题
Şükran Şenyürek,Merve Duman,Sena Birsen Güçlü et al.
Şükran Şenyürek et al.
Objective: Regional nodal irradiation (RNI) is one of the main causes of breast cancer-related lymphedema (BCRL). However, studies on the relationship between the radiation dose to the axillary-lateral thoracic vessel jun...
Pseudoangiomatous Hyperplasia of Mammary Stroma: Insights from Two Cases, Data Update and Management Algorithm [0.03%]
叶状结缔组织增生症：两例报告、数据更新及处理方法
Caroline Bouche,Thibaut Wolf,Mégane Buttignol et al.
Caroline Bouche et al.
Pseudoangiomatous stromal hyperplasia (PASH) is a benign breast lesion frequently discovered incidentally during imaging or biopsy for other conditions. We present two cases of PASH associated with fibroadenomas in premenopausal women, both...
Isolated Ileocecal Metastasis from Lobular Carcinoma of the Breast: A Case Report [0.03%]
孤立性乳腺小叶癌回肠炎性肉芽肿病的病例报告
Lakshmi Radhakrishnan,Ramita Mukherjee,Brijesh Kumar Singh et al.
Lakshmi Radhakrishnan et al.
Invasive lobular carcinoma (ILC) is the second most common histologic subtype of invasive breast cancer, accounting for 5-15% of this type. Though its unique propensity to metastasize to the extra-hepatic gastrointestinal tract is well know...
Evaluation of Tissue Expression of HMBG1 protein in Patients With Breast Cancer [0.03%]
乳腺癌患者HBMEG1蛋白组织表达状况分析
Gülden Diniz,İsmail Güzeliş,Dudu Solakoğlu Kahraman et al.
Gülden Diniz et al.
Objective: High mobility group box 1 (HMGB1) is a nonhistone chromatin-associated protein involved in chromatin remodeling, transcription, DNA replication, and repair. The purpose of this study was to assess the relations...
What Changes are Mandatory in Breast Surgery Training? An International Survey and Recommendations of the French Academy of Surgery and the Senologic International Society [0.03%]
乳房外科培训的强制性变化是什么？法国外科学院和国际乳腺学会的国际调查与建议
Tolga Ozmen,Caroline Bouche,Megane Buttignol et al.
Tolga Ozmen et al.
Objective: Breast cancer management has significantly evolved, particularly in surgical techniques, but breast surgery training remains unstandardized worldwide. This study, promoted by the Senologic International Society...
Bilateral Gestational Gigantomastia Complicating Pregnancy: A Challenging Case Refractory to Conservative Management [0.03%]
妊娠期双侧巨乳症的一个保守治疗无效的病例报告
Sathasivam Pravanan,Lakindu Grero,Widuranga Wijerathna et al.
Sathasivam Pravanan et al.
Gestational gigantomastia (GG) is a rare condition characterized by excessive and rapid breast enlargement during pregnancy, resulting in significant physical discomfort, functional limitations, and significant psychological impact. We pres...
Amal Alimi,Hafedh Abbassi,Skander Abid et al.
Amal Alimi et al.
Primary breast leiomyosarcoma is an extremely rare malignancy, accounting for approximately 1% of breast tumors and less than 5% of soft tissue sarcomas. Due to its rarity, standardized treatment guidelines remain unclear. We report the cas...